BriaCell Therapeutics Corp. Warrant expiring 2030 Share Price
NASDAQ: BCTXZ | Micro Cap$0.29
+$0.29 (--%) Last updated on 03 Oct, 2026 | 01:29 ISTBriaCell Therapeutics Corp. Warrant expiring 2030 Stock Performance
BriaCell Therapeutics Corp. Warrant expiring 2030 Share Price Chart
$0.28$0.28
L
H
BriaCell Therapeutics Corp. Warrant expiring 2030 Quarterly Profit & Loss
All figures in USD
BriaCell Therapeutics Corp. Warrant expiring 2030 Annual Profit & Loss
All figures in USD
About BriaCell Therapeutics Corp. Warrant expiring 2030
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
BriaCell Therapeutics Corp. Warrant expiring 2030 Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.28 | $0.28 | +47.37% |
Sep 2026 | $0.19 | $0.19 | +126.19% |
Aug 2026 | $0.08 | $0.08 | -6.67% |
Jul 2026 | $0.10 | $0.09 | +12.50% |
Jun 2026 | $0.08 | $0.08 | -11.11% |
Apr 2026 | $0.15 | $0.09 | -21.05% |
Mar 2026 | $0.16 | $0.11 | -25.49% |
Feb 2026 | $0.14 | $0.15 | -10.00% |
Jan 2026 | $0.28 | $0.17 | -37.04% |
Dec 2025 | $0.42 | $0.27 | -16.41% |
Nov 2025 | $0.36 | $0.32 | -22.54% |
Oct 2025 | $0.34 | $0.42 | +26.36% |